Oncology

How if scientific innovation transforming precision oncology? Simon Lord, Associate Professor in Experimental Cancer Therapeutics at the University of Oxford shares his expertise.

Stephen Freedland explores how lifestyle, equity, and emerging therapeutics are reshaping prostate cancer care, from risk to survivorship.

In this episode Jonathan is joined by Jean Abraham, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.

Lennard Lee, Associate Professor of Cancer Vaccines at the University of Oxford, shares how large-scale collaboration is shaping the future of cancer vaccines and oncology innovation.

Bradley Monk, Medical Director of Late-Phase Clinical Research at Florida Cancer Specialists, shares key understandings from the Society of Gynecologic Oncology (SGO) 2025, alongside a fascinating deep dive into drug approval and access.

Bradley Monk, Medical Director of Late-Phase Research at Florida Cancer Specialists, shares his insights from ESGO 2025 and landmark studies in gynaecologic oncology.

Joan Carles, Vall d’Hebron, shares insights on anti-angiogenic therapies, resistance in GU cancers, and the future of personalised oncology.

Janice Walshe, Consultant Medical Oncologist at St Vincent’s University Hospital in Dublin, explores access to innovation in cancer care, the challenges of fertility preservation, and the future of oncology in Ireland.

Alexander Spira, Director of the Thoracic and Phase I Program at Virginia Cancer Specialists, explores breakthroughs in lung and colorectal cancer treatment.

This episode focuses on the implications of ESR1 mutations in oestrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast…

Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, shares new frontiers in liver cancer treatment.

Sebastian Stintzing, Head of Department of Medicine, Division of Hematology, Oncology, and Cancer Immunology, Charité – Universitäetsmedizin, Berlin, Germany, discusses the most impactful research into metastatic colorectal cancer.

Heather McArthur, Associate Professor in the Department of Medicine at University of Texas, UT Southwestern Medical Center, discusses recent advancements in breast cancer immunotherapy, and the future of personalised care.

Donal Brennan shares insights on ovarian cancer surgery, obesity-related carcinogenesis, and innovations in patient care.

Join Dr Dave Cescon as he shares insights into the evolving landscape of breast cancer care and translational research.

Janet Abrahm, Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute breaks stigmas around palliative care and supportive oncology.